This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Lannett Company Inc., priced at $0.3509 per EA under NDC 00527076337. Its NADAC has been published 162 times since Oct 11, 2023.

FDA first approved this application on Jul 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

00527076337

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215565

FDA Approved

7/8/2022

TE Code

AB

On Market Since

7/8/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 162 times since Oct 11, 2023, and over the history we have for it it has declined 34.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3509 per EA
All-time high$0.5319 (Oct 11, 2023)
All-time low$0.2862 (Nov 20, 2024)
52-week high$0.3592
52-week low$0.3065
Median price$0.3678
Average price$0.3927
Largest weekly change-45.1% (Nov 20, 2024)
Weeks tracked162
Tracking sinceOct 11, 2023

Price History

1W

0.0%

1M

-2.3%

3M

+1.9%

6M

+14.5%

1Y

+2.5%

3Y

-32.8%

5Y

N/A

All

-34.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Lannett Company Inc., is $0.3509 per EA (NDC 00527076337), effective Nov 11, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 34.0%. It has been tracked across 162 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Oct 11, 2023, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.5319 (Oct 11, 2023), with a median of $0.3678 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 00527076337) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAM 12.5 MG TAB in shortage?

Yes — NDC 00527076337 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).